A leading contract drug development organisation, helping you realise the full potential of your innovation. It’s our goal to see every viable therapeutic asset succeed.
From concept to reality, we offer strategic expertise and operational support at every step; helping to expedite the development of new medicines, medical devices and combination products. Our experienced physicians, scientists and regulatory experts offer truly flexible expertise and support, to allow you to drive your future innovation. We can help you build your product strategy and define best route to market as well as design and execute your development programmes.
Our biotech consulting team of experts works across a diverse range of therapy areas. We lead and support projects in oncology, immunology, infectious diseases, respiratory medicine and neurology, just to name a few.
We are highly skilled in the development of small molecules, biologics and advanced therapies. We have years of experience in therapeutic areas with high unmet medical needs, including orphan and rare diseases.
The tranScrip team is a regular contributor at events, conferences, webinars, trade shows and seminars. Whenever they’re called upon, our experts are proud to attend as presenters, exhibitors and delegates at key therapeutic area and drug development congresses, worldwide.
ESMO 2023 will disseminate the latest cutting-edge data, provide high quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around...
Now in its 14th annual edition, the World Orphan Drug Congress Europe will continue to bring experts from the whole value chain under one...
We have teams of life science and R&D experts to help achieve your goals and seize opportunities. Whatever your project requires, we have the people to meet your needs.